Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EPB-348 vs Valacyclovir in Acute Herpes Zoster
NCT00831103Phase 2Completed
- Sponsor
- Epiphany Biosciences
- Start
- Nov 2007
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of valomaciclovir in herpes zoster (HZ), sponsored by Epiphany Biosciences. Started Nov 2007; status: completed.
02
Drugs
valomaciclovir
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT00831103.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00831103.